3rd VPH Study Group on VPH Toolkit

07 - 11 May 2012, Barcelona, Spain.
The third VPH NoE study group (SG3), organised by the University of Sheffield, Super Computing Solutions, Istituto Ortopedico Rizzoli, and Universitat Pompeu Fabra, will take place at UPF premises the week after the IEEE International Symposium on Biomedical Imaging (ISBI 2012).

Following the success of previous study groups organised by the VPH NoE Consortium, the format of SG3 will be quite similar to that of SG1 and SG2. The organisers invited three groups of world-recognised experts, typically leading large VPH Projects, to submit a proposal for a grand challenge in the area of musculoskeletal, cardiovascular, and oncology research. The organisers requested that these grand challenges would identify each a challenging modelling workflow, a minimum list of "essential" tools known to be necessary, and a list of European research groups that are known to be active in research topics that could benefit from the complete realisation of such workflow.

  • Norbert Graf, USAAR Saarland, coordinator of the P-medicine project, and Georgios Stamatakos, ICCS Athens, coordinator of the Oncosimulator Project proposed "Multiscale cancer models and oncosimulators for clinical use";
  • Fulvia Taddei, Istituto Ortopedico Rizzoli, co-coordinator of the VPHOP project, and Damien Lacroix, IBEC Barcelona, coordinator of the MYSPINE project proposed "Multiscale models of the skeleton for clinical use";
  • Blanca Rodriguez, University of Oxford, Pras Pathmanathan, University of Oxford, Pablo Lamata, Kings College London/University of Oxford and Mariano Vazquez, Barcelona Supercomputing Centre proposed "Multiscale multiphysics modelling and simulation of the cardiovascular system".

For each challenge a workgroup will be formed, composed by the experts who proposed the challenge, expert developers of software tools identified relevant for that challenge, and by young researchers (PhD students and post-docs) who are conducting research in directions that would take clear advantage by the full realisation of the workflow defined by the challenge.

The first day the three keynote speakers will present each challenge during a plenary session, so as to promote cross-fertilisation between the three research areas. An additional plenary lecture for each challenge will be given in the following days. From the afternoon of the first day to the end of the forth day the three workgroups will collaborate to the development of the three workflows, and to their applications to the specific research problems of each participant. The fifth day the three workgroups will meet again in plenary session, to wrap-up the results of the study group, again with cross-fertilisation intent.

For tool developers the event will be an opportunity to "evangelise" young researchers on the use of their tools, but also a perfect opportunity to understand what are the difficulties that VPH researchers find in using software of the VPH toolkit, so as to improve the tools and make them more effective. Last, but not least, it will give to tool developers the opportunity to hack interoperability solutions to compose multiple tools into relevant workflows.

For young researchers it will be the perfect opportunity to be brought at the state of the art from a methodological point of view, we the possibility to try multiple software tools pertinent to the their research project, under the direct guidance of the tools developers. It will also give the opportunity to find synergies and common solutions to problems emerging from distinct research problems.

In order to make the study groups effective, the event is open to a maximum of 60 participants between tool developers or young researchers, 20 for each study group. If you are interested please complete the Application Form and submit it according to the instructions no later than January 15th, 2012. We reserve the right to discard any application received after this date.

The organisers and the challenge leaders will rank the applications, primarily on the basis of the relevance of the tool / research project of the applicant. The first 60 applicants will be invited to attend no later than February 15th, 2012.

Participants are expected confirm their participation no later than March 30th, 2012. To the applicants ranked in the first 60 places, who are affiliated to a not-for-profit organisation, the VPH NoE will cover the costs of the registration fee, and will provide free accommodation.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...